Collectively, these results support our hypothesis that EGFR plays a more critical role is a pivotal receptor in promoting the proliferation of HNSCC cells following long-term treatment with NNK and arecoline. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.